Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Inhibition of FGFR1/2 decreases oligodendrocyte proliferation through ERK signaling in vitro
Multiple Sclerosis
P1 - (-)
398
Authors/Disclosures
Vinothkumar Rajendran (Justus-Liebig University)
PRESENTER 		Mr. Rajendran has nothing to disclose.
Ranjithkumar Rajendran (Justus Liebig University) Mr. Rajendran has nothing to disclose.
Martin Berghoff, MD, FÂ鶹´«Ã½Ó³»­ (BundeswehrZentralkrankenhaus Koblenz) Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.